LAURA BUTTERWICK: Open Payments
NPI 1184695363 · SOUTHAMPTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,582 in 159 payments from 22 companies in 2025. Trend: 2023 $1,416 · 2024 $2,387 · 2025 $2,582
Food & beverage: $2,563Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $455 |
| PFIZER INC. | 16 | $271 |
| Novo Nordisk Inc | 14 | $221 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $211 |
| AstraZeneca Pharmaceuticals LP | 10 | $164 |
| Amgen Inc. | 9 | $144 |
| Lilly USA, LLC | 6 | $125 |
| Abbott Laboratories | 5 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $119 |
| GlaxoSmithKline, LLC. | 6 | $111 |
Products named: VRAYLAR, XIFAXAN, UBRELVY, NURTEC ODT, MOUNJARO, FREESTYLE LIBRE 3, CAPLYTA, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
